Ali Alhamza
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Ali Alhamza has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
Amy Malhowski
Laboratory of Genome Integrity Center for Cancer Research National Cancer Institute National Institutes of Health Bethesda MD USA
1 shared publicationAndré Nussenzweig
Laboratory of Genome Integrity Center for Cancer Research National Cancer Institute National Institutes of Health Bethesda MD USA
1 shared publication- Dharm S. Patel
A Department of Molecular Biology and Biochemistry, Rutgers , The State University of New Jersey , Piscataway , NJ , USA
1 shared publication - Francesca Cole
Department of Epigenetics and Molecular Carcinogenesis, Division of Basic Sciences, The University of Texas MD Anderson Cancer Center , Houston, TX 77030
1 shared publication Haiyan Zheng
Biological Mass Spectrometry Facility Rutgers The State University of New Jersey Piscataway NJ USA
1 shared publicationJoonyoung Her
Department of Molecular Biology and Biochemistry Rutgers The State University of New Jersey Piscataway NJ USA
1 shared publication
Latest Publications
- 26 September 2016
- Published by Springer Nature in EMBO Reports
- Vol. 17 (11) , 1532-1541
53BP1 ablation rescues genomic instability in mice expressing ‘RING‐less’ BRCA1
BRCA1 mutations strongly predispose affected individuals to breast and ovarian cancer, but the mechanism by which BRCA1 acts as a tumor suppressor is not fully understood. Homozygous deletion of exon 2 of the mouse Brca1 gene normally causes embryonic lethality, but we show that exon 2‐deleted alleles of Brca1 are expressed as a mutant isoform that lacks the N‐terminal RING domain. This “RING‐less” BRCA1 protein is stable and efficiently recruited to the sites of DNA damage. Surprisingly, robust RAD51 foci form in cells expressing RING‐less BRCA1 in response to DNA damage, but the cells nonetheless display the substantial genomic instability. Genomic instability can be rescued by the deletion of Trp53bp1 , which encodes the DNA damage response factor 53BP1, and mice expressing RING‐less BRCA1 do not show an increased susceptibility to tumors in the absence of 53BP1. Genomic instability in cells expressing RING‐less BRCA1 correlates with the loss of BARD1 and a defect in restart of replication forks after hydroxyurea treatment, suggesting a role of BRCA1–BARD1 in genomic integrity that is independent of RAD51 loading. ![][1] BRCA1 protein lacking the N‐terminal RING domain is stable and supports RAD51 focus formation at DSBs. Cells with “RING‐less” BRCA1 nonetheless show genomic instability, likely because of BARD1 loss and impaired stalled replication fork restart. EMBO Reports (2016) 17: 1532–1541 [1]: /embed/graphic-1.gif
- 26 September 2016
- Published by Springer Nature in EMBO Reports
- Vol. 17 (11) , 1532-1541
53BP1 ablation rescues genomic instability in mice expressing ‘RING‐less’ BRCA1
BRCA1 mutations strongly predispose affected individuals to breast and ovarian cancer, but the mechanism by which BRCA1 acts as a tumor suppressor is not fully understood. Homozygous deletion of exon 2 of the mouse Brca1 gene normally causes embryonic lethality, but we show that exon 2‐deleted alleles of Brca1 are expressed as a mutant isoform that lacks the N‐terminal RING domain. This “RING‐less” BRCA1 protein is stable and efficiently recruited to the sites of DNA damage. Surprisingly, robust RAD51 foci form in cells expressing RING‐less BRCA1 in response to DNA damage, but the cells nonetheless display the substantial genomic instability. Genomic instability can be rescued by the deletion of Trp53bp1 , which encodes the DNA damage response factor 53BP1, and mice expressing RING‐less BRCA1 do not show an increased susceptibility to tumors in the absence of 53BP1. Genomic instability in cells expressing RING‐less BRCA1 correlates with the loss of BARD1 and a defect in restart of replication forks after hydroxyurea treatment, suggesting a role of BRCA1–BARD1 in genomic integrity that is independent of RAD51 loading. ![][1] BRCA1 protein lacking the N‐terminal RING domain is stable and supports RAD51 focus formation at DSBs. Cells with “RING‐less” BRCA1 nonetheless show genomic instability, likely because of BARD1 loss and impaired stalled replication fork restart. EMBO Reports (2016) 17: 1532–1541 [1]: /embed/graphic-1.gif